George Neidich

Imperial Capital Group Ltd (Imperial Capital) is a private equity firm founded in 1989 by Stephen D. Lister and Jeffrey Rosenthal. The firm is headquartered in Toronto, Canada.

STI Technologies Ltd. provides marketing solutions to the health care industry. The firm's SmartTechnology platform allows stakeholders-manufacturers, pharmacies, prescribers, and payers to optimize their patient relationships. It offers solutions for pre-launch planning, brand adoption, market uptake, revenue optimization, retention and adherence, and loss of exclusivity. The company was founded by William B. Adams and Gregory Patey in 2001 and is headquartered in Halifax, Canada.

AIM Health Group, Inc. provides healthcare services. It offers medical, health and wellness programs, pharmacy, and rehabilitation services as well as the complementary alternative medicine. The company was founded by Luciano Michael Barbuto in 1990 and is headquartered in Mississauga, Canada.

The Catalyst Capital Group Inc (catalyst capital group) is private equity firm founded in 2002 by Jeremy Keele, Patrick McKenna, James Lee Sorenson. The firm is headquartered in Ontario, Canada.

Touchtunes Digital Jukebox, Inc. engages in the manufacture of musical devices. The company was founded on March 18, 1998 and is headquartered in Montreal, Canada.

Searchlight Capital Partners LP (Searchlight Capital Partners) is a private equity investment firm founded in 2010 by Eric Zinterhofer, Erol Uzumeri, and Oliver Haarmann. The firm is headquartered in New York with additional offices in London and Toronto.

Mavencare, Inc. offers personalized home care services. It provides home health care, companionship, transportation and nursing services. The company was founded in 2014 by James Cohen and Adam Blackman and is headquartered in Toronto, Canada.

Pentavere Research Group, Inc. is a Canadian AI digital health company that has developed an AI engine called Darwen™ to identify patients who are eligible for approved medications or interventions. The private company aims to improve patient outcomes and drive therapy growth and penetration. Pentavere's AI system helps identify patients who are eligible for but not receiving approved medications or interventions, thus improving outcomes for patients and driving appropriate therapy growth and penetration. The company also accelerates the discovery of insights and evidence buried in vast amounts of clinical information that is impossible to analyze by human intelligence alone.